No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Cancer Metabolism Based Therapeutic market is a subset of the Oncology Drugs market, focusing on treatments that target the metabolic pathways of cancer cells. These treatments are designed to disrupt the metabolic processes of cancer cells, such as glucose uptake, fatty acid oxidation, and amino acid metabolism, in order to inhibit their growth and proliferation. This approach is particularly useful for targeting cancer cells that have become resistant to traditional chemotherapy and radiation treatments.
The Cancer Metabolism Based Therapeutic market is a rapidly growing field, with many companies developing new treatments and therapies. Some of the major players in this market include Merck, Pfizer, Novartis, AstraZeneca, and Bristol-Myers Squibb. Other companies, such as Celgene, GlaxoSmithKline, and Sanofi, are also actively researching and developing new treatments in this area. Show Less Read more
